Skip to main content
Clinical Trials/NL-OMON53149
NL-OMON53149RecruitingNot Applicable

Wear, bone density, functional outcome and survival of vitamin E incorporated polyethylene cups in reversed hybrid total hip arthroplasty: a randomized controlled trial - E-Vita

Martini Ziekenhuis0 sites150 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 64 (—)

Inclusion Criteria

  • 1. Primary osteoarthritis of the hip
  • 2. Age < 70 years

Exclusion Criteria

  • 1. Secondary osteoarthritis of the hip
  • 2. (Active) arthritis (eg rheumatic disease)
  • 3. Peripheral neuropathy
  • 4. History of CVA
  • 5. Cognitive impairments (eg dementia)

Investigators

Similar Trials

Not yet recruiting
Not Applicable
WEAR, BONE DENSITY, FUNCTIONAL OUTCOME AND SURVIVAL IN VITAMIN E INCORPORATED CUPS IN TOTAL HIP ARTHROPLASTY: A RANDOMIZED CONTROLLED TRIAL.Total Hip Arthroplasty, Vitamin E, polyethylene, wear
NL-OMON22433Martini Hospital, Department of Orthopaedic Surgery; University Medical Center Groningen (UMCG), Department of Orthopaedic Surgery150
Completed
Not Applicable
Effect on bone turnover and Bone Mineral Density (BMD) of low dose oral silicon as an adjunct to calcium/vitamin D3 in a randomised, placebo-controlled trial
ISRCTN57103074Bio Minerals N.V. (Belgium)184
Active, not recruiting
Phase 1
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody.An investigator-led, industry supported, multicentre, open-label, single treatment arm, prospective clinical trial. - Effects of B cell depletion on bone turnover in rheumatoid arthritis.rheumatoid arthritis
EUCTR2010-020499-50-GBSouth Tees Hospitals NHS Foundation Trust46
Completed
Not Applicable
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting antibodyRheumatoid arthritis
ISRCTN82317088South Tees Hospitals NHS Foundation Trust (UK)46
Completed
Not Applicable
The Effect on Behavior and Bone Mineral Density of Individualized Bone Mineral Density Feedback and Educational Interventions in Premenopausal Women: a Randomized Controlled Trial.Osteoporosis
ACTRN12605000139673niversity of Tasmania400
Wear, bone density, functional outcome and... | Clinical Trial